Inactive Instrument

Calendar Almirall SA CBOE EUROPE EQUITIES

Equities

ES0157097017

Real-time Estimate Tradegate 07:11:30 26/06/2024 BST
9.613 EUR 0.00% Intraday chart for Almirall SA

Chart calendar Almirall SA

6e0b66a53d25e11db4b6db15c0.mbIDBqfL0bmVB5_wKQ1F0FY3m4N2DImGse-aSmUs3B8.29NEf-iKhOnzSrKbGE4mmTBUqPoXQ7_F64rwGDAf5VSu8Dtg5bG30qRG6A~edf7e54ac70c402b23d6d0a6b2c56fee

Upcoming events on Almirall SA

21/07/2024 Q2 2024 Earnings Release
10/11/2024 Q3 2024 Earnings Release
23/02/2025 Q4 2024 Earnings Release (Projected)
18/05/2025 Q1 2025 Earnings Release (Projected)
27/07/2025 Q2 2025 Earnings Release (Projected)
16/11/2025 Q3 2025 Earnings Release (Projected)

Past events on Almirall SA

16/05/2024 Détachement de for Cash amount paid with the scrip issue offered as an alternative to the dividend
13/05/2024 09:00 Q1 2024 Earnings Call
13/05/2024 06:16 Q1 2024 Earnings Release
11/05/2024 12:00 Shareholders Meeting - Second Call
10/05/2024 12:00 Annual General Meeting - First Call
19/02/2024 09:00 Q4 2023 Earnings Call
19/02/2024 06:02 Q4 2023 Earnings Release
09/01/2024 17:00 JPMorgan Healthcare Conference
09/11/2023 09:00 Q3 2023 Earnings Call
09/11/2023 06:28 Q3 2023 Earnings Release
10/10/2023 European Academy of Dermatology and Venereology Congress - Abstract No 3491
10/10/2023 European Academy of Dermatology and Venereology Congress - Abstract No 3110
10/10/2023 European Academy of Dermatology and Venereology Congress - Abstract No 3492
10/10/2023 European Academy of Dermatology and Venereology Congress - Abstract No 3489
10/10/2023 European Academy of Dermatology and Venereology Congress - Abstract No 3122
10/10/2023 European Academy of Dermatology and Venereology Congress - Abstract No 3123
10/10/2023 European Academy of Dermatology and Venereology Congress - Abstract No 3121
10/10/2023 European Academy of Dermatology and Venereology Congress - Abstract No 3120
10/10/2023 European Academy of Dermatology and Venereology Congress - Abstract No 3106
10/10/2023 European Academy of Dermatology and Venereology Conference - Abstract No 3490

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
853
869
-1.87%
807
821
-1.66%
810
821
-1.31%
863
859
0.48%
895
903
-0.94%

975

EBITDA
Million EUR
Released
Forecast
Spread
304
307
-0.87%
238
244
-2.37%
236
218
7.85%
198
194
2.1%
174
175
-0.47%

186

EBIT
Million EUR
Released
Forecast
Spread
175
175
-0.18%
115
121
-4.73%
116
116
-0.47%
46,9
70,8
-33.78%
49,8
49,9
-0.28%

54,9

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
128
157
-18.17%
79,2
89,8
-11.76%
-9,09
-9,17
0.89%
31,0
43,0
-27.81%
-17,2
37,0
-146.42%

41,9

Net income
Million EUR
Released
Forecast
Spread
106
116
-8.51%
74,3
73,8
0.68%
-40,9
-27,4
-48.98%
4,28
28,1
-84.76%
-38,5
17,2
-323.5%

21,6

EPS
EUR
Released
Forecast
Spread
0,60
0,67
-10.22%
0,44
0,44
0.92%
-0,23
-0,17
-36.6%
0,02
0,20
-89.87%
-0,20
0,08
-348.51%

0,10

Announcement Date24/02/2022/02/2121/02/2220/02/2319/02/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million EUR
Released
Forecast
Spread
426
421
1.18%
426
422
1.03%
208
200
4.05%
219
216
1.28%
218
214
1.55%
437
435
0.41%
197
202
-2.26%
229
208
10.27%
232
226
2.65%
234
224
4.62%
466
456
2.16%
209
206
1.04%
220
222
-1.04%
247
241
2.7%

250


236


244

EBITDA
Million EUR
Released
Forecast
Spread
137
133
3.2%
137
128
6.69%
54,4
44,3
22.75%
50,3
49,9
0.84%
48,0
48,2
-0.33%
108
104
3.96%
38,8
38,6
0.47%
51,9
54,2
-4.19%
51,8
45,3
14.43%
49,5
43,8
12.98%
101
95,6
6.02%
36,9
33,1
11.59%
35,9
37,2
-3.39%
52,5
47,0
11.7%

50,8


42,1


45,1

EBIT
Million EUR
Released
Forecast
Spread
75,3
70,5
6.77%
77,6
71,8
8.08%
23,0
15,3
49.84%
30,3
20,4
48.53%
17,9
18,9
-5.36%
48,2
47,0
2.61%
7,90
8,51
-7.17%
-9,23
18,7
-149.43%
20,3
17,1
18.48%
18,6
14,3
29.54%
38,9
32,6
19.34%
5,90
4,50
31.11%
5,40
13,5
-60%
18,5
16,1
14.91%









Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
50,4
66,2
-23.83%
-26,9
60,9
-144.23%
10,0
11,4
-12.15%
28,1
15,1
85.68%
13,7
15,0
-8.67%
41,8
43,0
-2.79%
-18,5
4,20
-540.48%
7,73
13,5
-42.66%
7,70
11,9
-35.29%
12,7
9,15
39.05%
28,1
24,3
15.89%
8,40
3,60
133.33%
-53,7
4,30
-1348.63%
15,1
7,00
115.71%

14,6


5,90


8,90

Net income
Million EUR
Released
Forecast
Spread
42,4
55,5
-23.65%
-42,8
50,2
-185.3%
-1,46
13,1
-111.17%
20,4
11,6
75.86%
6,90
10,7
-35.31%
27,3
29,7
-7.98%
-16,4
2,83
-678.82%
-6,62
12,8
-151.79%
7,70
8,65
-10.98%
4,32
5,54
-22.11%
12,0
12,8
-5.76%
1,59
-1,73
192.17%
-52,1
6,03
-963.11%
7,40
2,80
164.29%

5,90


2,40


3,60

EPS
EUR
Released
Forecast
Spread
0,25
0,32
-21.88%
-0,24
0,29
-182.76%
-0,01
0,02
-150%
0,11
0,06
83.33%
0,04
0,05
-20%



-0,09
0,02
-550%
-0,04
0,08
-150%

0,05


0,03





-0,03


-0,02


0,01


0,03


0,01


0,02

Announcement Date27/07/2026/07/2121/02/2209/05/2225/07/2225/07/2210/11/2220/02/2308/05/2324/07/2324/07/2309/11/2319/02/2413/05/24---